Singapore
Report
Trust Imperative 5.0: building trust in government through practical AI assurance
Governments have moved rapidly from experimenting with artificial intelligence (AI) to deploying it. But a gap has emerged between governments’ ambition to scale AI and their ability to deploy systems with confidence. This report finds that most governments have established AI ethics principles, governance models or national frameworks. The challenge lies in day-to-day execution.
Guide
Positive use guide: evidence-based insights on the impact of digital devices on child and adolescent wellbeing
This guide provides evidence-based practical tips and checklists on how to manage screen time for children and adolescents in Singapore to help them build a normalised, lifelong relationship with technology. The guide discusses how screen use has both positive and negative effects. It finds screen use has a less significant role in wellbeing than other...
Guide
Thinking about tomorrow: a handbook for strategic foresight
This handbook offers an understanding of foresight – what is found true in theory and useful in practice. Foresight offers a distinctive way of thinking about change, one that helps people and organisations work with uncertainty. It is written mainly for public sector foresight practitioners, and is designed to be read linearly or modularly.
Report
Made to manipulate: the impact of deceptive online design practices on wellbeing and strategies to mitigate harm
This report describes what Australia can learn from other countries in tackling deceptive and manipulative online design features. It finds that Australia is falling behind and lacks economy-wide protections against unfair trading practices. The report makes recommendations for government, regulators and businesses.
Strategy
Access Consortium strategic plan 2025-2028
The Access Consortium comprises the medicine and healthcare regulatory agencies of Australia, Canada, the UK, Singapore and Switzerland. This updated strategic plan outlines the Consortium's approach to regulatory collaboration, streamlined processes and improved access to safe and effective medicines. Key objectives include encouraging joint applications and supporting regulatory innovation.